Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.287NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.170NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.506NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.438.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.188NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.494NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.165NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.554NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.243.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.5.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.450NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.130NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AW.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.268NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.344NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.103NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.485NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.119NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.276NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.111NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.336NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.400.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.24.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.492NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.540NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.487NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.118NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.357NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.530NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.17.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.570NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.633NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.136NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAYNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used